您的位置: 首页 > 农业专利 > 详情页

Anti-CCR7 antibody drug conjugates
专利权人:
Novartis AG
发明人:
Bender, Steven,Charlton, Tracy,Galkin, Anna,Geierstanger, Bernhard Hubert,Glaser, Scott Martin,Kasibhatla, Shailaja,Knuth, Mark,Rottmann, Sabine,Rue, Sarah,Spraggon, Glen,Uno, Tetsuo
申请号:
AU2018215701
公开号:
AU2018215701A1
申请日:
2018.02.01
申请国别(地区):
AU
年份:
2019
代理人:
摘要:
This application discloses anti-CCR7 antibodies, antigen binding fragments thereof, and antibody drug conjugates of said antibodies or antigen binding fragments. The invention also relates to methods of treating or preventing cancer using the antibodies, antigen binding fragments, and antibody drug conjugates. Also disclosed herein are methods of making the antibodies, antigen binding fragments, and antibody drug conjugates, and methods of using the antibodies and antigen binding fragments as diagnostic reagents.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充